Concepedia

Geoffrey Bilcer

GB

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2000

Affiliations

University of Illinois Chicago(Current)

Oklahoma Medical Research Foundation

University of Oklahoma

University of Oklahoma Health Sciences Center

Oklahoma Foundation for Medical Quality

Geoffrey Bilcer is an author at University of Illinois Chicago specializing in medicinal chemistry, drug design, and enzyme inhibition.

Publications per year

2000–2014

11

Publications

11

Novel <i>bis</i> -Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro

Yasuhiro Koh, Hirotomo Nakata, Kenji Maeda et al. · Antimicrobial Agents and Chemotherapy · 2003 · 366 citations · Full text

, , +17

The Microtubule Stabilizing Agent Laulimalide Does Not Bind in the Taxoid Site, Kills Cells Resistant to Paclitaxel and Epothilones, and May Not Require Its Epoxide Moiety for Activity

Donald E. Pryor, Aurora O’Brate, Geoffrey Bilcer et al. · Biochemistry · 2002 · 255 citations

, , +17

Structure-Based Design:  Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)

Arun K. Ghosh, Geoffrey Bilcer, Cynthia Harwood et al. · Journal of Medicinal Chemistry · 2001 · 224 citations · Full text

, , +17

Syntheses of FDA Approved HIV Protease Inhibitors

Arun K. Ghosh, Geoffrey Bilcer, Gary E. Schiltz · Synthesis · 2001 · 118 citations · Full text

, , +12

<i>In vivo</i> inhibition of Aβ production by memapsin 2 (β‐secretase) inhibitors

Wan‐Pin Chang, Gerald Koelsch, Stephen T.C. Wong et al. · Journal of Neurochemistry · 2004 · 103 citations

, , +17

1–5 of 11